Analysis of survival outcomes in patients with non–small-cell lung cancer with mutations in STK11/LKB1 receiving chemoimmunotherapy von Kim, Diana, Elsey, Rachel, Meissner, Tobias, Sun, Yuliang, Xu, Bing, Hattum, Crystal, Solomon, Benjamin Maurice, Lee, John H., Williams, Casey B.

Volltext

Implementation of the Avera/Sema4 oncology and analytics protocol (ASAP) von Williams, Casey B., Starks, David, Elsey, Rachel, Meissner, Tobias, Solomon, Benjamin Maurice, Albano, Melanie, Hantash, Feras, Schadt, Eric, Rojas-Espaillat, Luis Alexander, Lee, John H., Oh, William K.

Volltext

Evaluating the impact of a molecular tumor board in a community oncology center: Results from the Avera Cancer Institute's experience von Elsey, Rachel, Meissner, Tobias, Sun, Yuliang, Hattum, Crystal, McKean, Heidi Ann, Solomon, Benjamin Maurice, Starks, David, Rojas-Espaillat, Luis Alexander, Spanos, William Charles, Lee, John H., Williams, Casey B.

Volltext

Use of CLIA accredited multi-omic platforms to correlate clinical significance of WES/WTS testing with functional protein/phosphoprotein drug target activity von Elsey, Rachel, Meissner, Tobias, Mueller, Claudius, Corgiat, Brian, Davis, Justin B, Hattum, Crystal, Spanos, William Charles, Starks, David, Solomon, Benjamin Maurice, Petricoin, Emanuel, Lee, John H., Williams, Casey B.

Volltext

Clinical utility of comprehensive genomic profiling and targeted therapy in biliary tract cancers: A real-world experience von Shahid, Mahum, Abdallah, Mohamed A., Ellithi, Moataz, Abdullah, Hafez Mohammad, Nelson, Morgan, Solomon, Benjamin Maurice, Bleeker, Jonathan

Volltext

Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer von Lin, Jessica Jiyeong, Tan, Daniel Shao-Weng, Kummar, Shivaani, Patel, Jyoti D., Cermignani, Luciano, Dai, Ming-Shen, Lassen, Ulrik Niels, Leyvraz, Serge, Liu, Yongmei, Moreno, Victor, Rosen, Lee S., Saada-Bouzid, Esma, Solomon, Benjamin Maurice, Xu, Rui-Hua, Yachnin, Jeffrey, Norenberg, Ricarda, Burcoveanu, Domnita-Ileana, Mussi, Chiara E., Shen, Lin, Drilon, Alexander E.

Volltext

Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer von Lin, Jessica Jiyeong, Kummar, Shivaani, Tan, Daniel Shao-Weng, Lassen, Ulrik Niels, Leyvraz, Serge, Liu, Yongmei, Moreno, Victor, Patel, Jyoti D., Rosen, Lee S., Solomon, Benjamin Maurice, Norenberg, Ricarda, Dima, Laura, Brega, Nicoletta, Shen, Lin, Drilon, Alexander E.

Volltext

Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer von Drilon, Alexander E., Lin, Jessica Jiyeong, Kummar, Shivaani, Tan, Daniel Shao-Weng, Patel, Jyoti D., Lassen, Ulrik Niels, Leyvraz, Serge, Moreno, Victor, Rosen, Lee S., Solomon, Benjamin Maurice, Yachnin, Jeffrey, Liu, Yongmei, Dai, Ming-Shen, Norenberg, Ricarda, Fellous, Marc Mardoche, Mussi, Chiara Erminia, Shen, Lin

Volltext

Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded data set von Drilon, Alexander E., Farago, Anna F., Tan, Daniel Shao-Weng, Kummar, Shivaani, McDermott, Raymond S., Berlin, Jordan, Patel, Jyoti D., Brose, Marcia S., Leyvraz, Serge, Tahara, Makoto, Solomon, Benjamin Maurice, Reeves, John A., Fellous, Marc Mardoche, Brega, Nicoletta, Childs, Barrett H., Lassen, Ulrik Niels, Hong, David S.

Volltext

SPRING: A Worldwide Innovative Network (WIN) Consortium phase I study of triple therapy (avelumab, axitinib, and palbociclib) in advanced non-small cell lung cancer (NSCLC) with ge... von Solomon, Benjamin Maurice, Callejo, Ana, Bar, Jair, Berchem, Guy J., Bazhenova, Lyudmila, Saintigny, Pierre, Raymond, Eric, Girard, Nicolas, Sulaiman, Raed, Prouse, Bruce, Bresson, Catherine, Wunder, Fanny, Lee, J. Jack, Raynaud, Jacques, Rubin, Eitan, Lazar, Vladimir, Felip, Enriqueta, Onn, Amir, Leyland-Jones, Brian, Kurzrock, Razelle

Volltext

Value of sequencing-guided treatment for patients with advanced malignancies von Williams, Casey B., Goldberg, Robert, Williams, Kirstin Anne, De, Pradip, Rojas, Luis, Starks, David, Dey, Nandini, Klein, Jessica, Elsey, Rachel, McMillan, Amanda, Ye, Ping, Xu, Bing, Solomon, Benjamin Maurice, Krie, Amy K., Leyland-Jones, Brian

Volltext

Investigating the Utility of comprehensive genomic Profiling for patients with newly diagnosed breast cancer von Williams, Casey B., Goldberg, Robert, Williams, Kirstin Anne, De, Pradip, Klein, Jessica, Dey, Nandini, Young, Brandon Michael, Banks, Kimberly C., Lee, Christine Elaine, Lanman, Richard Burnham, Ali, Siraj Mahamed, Ross, Jeffrey S., Miller, Vincent A., Solomon, Benjamin Maurice, Krie, Amy K., Leyland-Jones, Brian

Volltext

Overall and cancer-specific survival of breast, colon, and lung cancer in patients with and without chronic lymphocytic leukemia: A SEER population-based study of over 1 million pa... von Solomon, Benjamin Maurice, Rabe, Kari G., Slager, Susan L, Brewer, Jerry D, Cerhan, James R., Shanafelt, Tait D.

Volltext

Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC. Reply von Zhou, Caicun, Solomon, Benjamin, Pérol, Maurice

Volltext

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC von Zhou, Caicun, Solomon, Benjamin, Loong, Herbert H., Park, Keunchil, Pérol, Maurice, Arriola, Edurne, Novello, Silvia, Han, Baohui, Zhou, Jianying, Ardizzoni, Andrea, Mak, M. Perez, Santini, Fernando C., Elamin, Yasir Y., Drilon, Alexander, Wolf, Jürgen, Payakachat, Nalin, Uh, Minji K., Rajakumar, Deborah, Han, Hongmei, Puri, Tarun, Soldatenkova, Victoria, Lin, A. Bence, Lin, Boris K., Goto, Koichi

Volltext

Selpercatinib or Chemotherapy in RET Fusion–Positive NSCLC von Dingemans, Anne-Marie C., Smit, Egbert F., Hendriks, Lizza E.L., Zhou, Caicun, Solomon, Benjamin, Pérol, Maurice

Volltext

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer von Solomon, Benjamin J, Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jürgen, Elamin, Yasir, Davis, Hannah M, Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K, F Loong, Herbert H, Novello, Silvia, Arriola, Edurne, Pérol, Maurice, Goto, Koichi, Santini, Fernando C

Volltext

Phase III study of selpercatinib vs chemotherapy plus /- pembrolizumab in untreated RET positive non-small-cell lung cancer von Solomon, Benjamin J., Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jurgen, Elamin, Yasir, Davis, Hannah M., Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K., Loong, Herbert H., Novello, Silvia, Arriola, Edurne, Perol, Maurice, Goto, Koichi, Santini, Fernando C.

Volltext

The folk psychology of souls von Bering, Jesse M.

Volltext

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer von Solomon, Benjamin J, Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jurgen, Elamin, Yasir, Davis, Hannah M, Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K, Loong, Herbert H. F, Novello, Silvia, Arriola Aperribay, Edurne, Pérol, Maurice, Goto, Koichi, Santini, Fernando C

Volltext